Allianz Asset Management GmbH Sells 47,246 Shares of Steris PLC (STE)
Allianz Asset Management GmbH cut its stake in shares of Steris PLC (NYSE:STE) by 33.5% in the fourth quarter, HoldingsChannel.com reports. The fund owned 93,800 shares of the medical equipment provider’s stock after selling 47,246 shares during the period. Allianz Asset Management GmbH’s holdings in Steris were worth $8,205,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently modified their holdings of the business. BlackRock Inc. lifted its holdings in shares of Steris by 3.4% during the fourth quarter. BlackRock Inc. now owns 7,184,409 shares of the medical equipment provider’s stock valued at $628,419,000 after acquiring an additional 239,200 shares during the period. American Century Companies Inc. lifted its holdings in shares of Steris by 14.6% during the fourth quarter. American Century Companies Inc. now owns 1,194,167 shares of the medical equipment provider’s stock valued at $104,454,000 after acquiring an additional 152,346 shares during the period. Wells Fargo & Company MN lifted its holdings in shares of Steris by 6.6% during the fourth quarter. Wells Fargo & Company MN now owns 1,105,452 shares of the medical equipment provider’s stock valued at $96,694,000 after acquiring an additional 68,881 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of Steris by 4.9% during the third quarter. Bank of New York Mellon Corp now owns 1,017,810 shares of the medical equipment provider’s stock valued at $89,974,000 after acquiring an additional 47,682 shares during the period. Finally, Macquarie Group Ltd. lifted its holdings in shares of Steris by 7.0% during the third quarter. Macquarie Group Ltd. now owns 885,960 shares of the medical equipment provider’s stock valued at $78,318,000 after acquiring an additional 57,700 shares during the period. 89.40% of the stock is owned by institutional investors.
Steris PLC (STE) opened at $95.02 on Wednesday. The company has a quick ratio of 2.22, a current ratio of 2.82 and a debt-to-equity ratio of 0.46. Steris PLC has a twelve month low of $67.55 and a twelve month high of $96.43. The stock has a market capitalization of $8,120.00, a PE ratio of 33.46 and a beta of 1.17.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 28th. Investors of record on Wednesday, February 28th will be issued a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.30%. This is a boost from Steris’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend is Tuesday, February 27th. Steris’s payout ratio is currently 43.66%.
In related news, VP Sudhir K. Pahwa sold 2,000 shares of Steris stock in a transaction dated Monday, January 29th. The stock was sold at an average price of $92.09, for a total value of $184,180.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of Steris stock in a transaction dated Monday, March 12th. The shares were sold at an average price of $95.50, for a total value of $955,000.00. The disclosure for this sale can be found here. Insiders sold 78,415 shares of company stock valued at $7,178,536 over the last ninety days. 2.55% of the stock is currently owned by company insiders.
A number of research analysts have issued reports on the company. KeyCorp reissued a “buy” rating and set a $103.00 price objective on shares of Steris in a report on Thursday, February 8th. Northcoast Research set a $102.00 price objective on Steris and gave the company a “buy” rating in a report on Thursday, February 8th. Zacks Investment Research cut Steris from a “buy” rating to a “hold” rating in a report on Wednesday, January 24th. Finally, Raymond James Financial reissued a “market perform” rating and set a $100.00 price objective on shares of Steris in a report on Wednesday, January 3rd. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Steris has an average rating of “Buy” and an average price target of $84.80.
ILLEGAL ACTIVITY WARNING: This news story was first reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another site, it was illegally stolen and reposted in violation of US and international trademark & copyright law. The correct version of this news story can be accessed at https://www.dailypolitical.com/2018/03/14/allianz-asset-management-gmbh-sells-47246-shares-of-steris-plc-ste.html.
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.